144 related articles for article (PubMed ID: 18185098)
1. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy.
Hashimoto M; Kawasaki K; Suzuki M; Mitani K; Murayama S; Mishina M; Oda K; Kimura Y; Ishiwata K; Ishii K; Inoue K
Neuroreport; 2008 Jan; 19(2):145-50. PubMed ID: 18185098
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers.
Ceravolo R; Antonini A; Volterrani D; Rossi C; Goldwurm S; Di Maria E; Kiferle L; Bonuccelli U; Murri L
Neurology; 2005 Dec; 65(12):1971-3. PubMed ID: 16380622
[TBL] [Abstract][Full Text] [Related]
3. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
Hwang WJ; Yao WJ
J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
[TBL] [Abstract][Full Text] [Related]
4. Pure autonomic failure with altered dopamine transporter imaging.
Compta Y; Martí MJ; Paredes P; Tolosa E
Arch Neurol; 2006 Apr; 63(4):604-5. PubMed ID: 16606777
[No Abstract] [Full Text] [Related]
5. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.
Krygowska-Wajs A; Kachergus JM; Hulihan MM; Farrer MJ; Searcy JA; Booij J; Berendse HW; Wolters ECh; Wszolek ZK
J Neural Transm (Vienna); 2005 Nov; 112(11):1487-502. PubMed ID: 15785861
[TBL] [Abstract][Full Text] [Related]
6. PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
Piccini P; Turjanski N; Brooks DJ
J Neural Transm Suppl; 1995; 45():123-31. PubMed ID: 8748617
[TBL] [Abstract][Full Text] [Related]
7. Distinct clinical features of predominant pre-synaptic and trans-synaptic nigrostriatal dysfunction in multiple system atrophy.
Ryu HS; Oh M; Oh JS; Moon H; Park KW; Lee C; You S; Kim MJ; Kim YJ; Kim J; Kim K; Kim JS; Chung SJ
J Neurol Sci; 2019 Jul; 402():100-106. PubMed ID: 31128455
[TBL] [Abstract][Full Text] [Related]
8. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
[TBL] [Abstract][Full Text] [Related]
9. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Cordes M; Poewe W
Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
[TBL] [Abstract][Full Text] [Related]
10. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
11. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Andersson DR; Nissbrandt H; Bergquist F
Eur J Neurosci; 2006 Jul; 24(2):617-24. PubMed ID: 16903863
[TBL] [Abstract][Full Text] [Related]
12. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
[TBL] [Abstract][Full Text] [Related]
13. Acute NMDA receptor antagonism induces biphasic striatal utilization of L-[beta-11C]DOPA: PET studies in the conscious monkey brain.
Tsukada H; Harada N; Nishiyama S; Fukumoto D; Kakiuchi T
Synapse; 2005 Aug; 57(2):116-9. PubMed ID: 15906382
[No Abstract] [Full Text] [Related]
14. Function of sigma1 receptors in Parkinson's disease.
Mishina M; Ishiwata K; Ishii K; Kitamura S; Kimura Y; Kawamura K; Oda K; Sasaki T; Sakayori O; Hamamoto M; Kobayashi S; Katayama Y
Acta Neurol Scand; 2005 Aug; 112(2):103-7. PubMed ID: 16008536
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.
Fridman EA; Osborne JR; Mozley PD; Victor JD; Schiff ND
Brain; 2019 Jul; 142(7):1887-1893. PubMed ID: 31505542
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
[TBL] [Abstract][Full Text] [Related]
17. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.
Guilarte TR; Burton NC; McGlothan JL; Verina T; Zhou Y; Alexander M; Pham L; Griswold M; Wong DF; Syversen T; Schneider JS
J Neurochem; 2008 Dec; 107(5):1236-47. PubMed ID: 18808452
[TBL] [Abstract][Full Text] [Related]
18. Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys.
Lai A; Sum J; Fan H; McIntosh JM; Quik M
Neuroscience; 2004; 127(2):399-408. PubMed ID: 15262330
[TBL] [Abstract][Full Text] [Related]
19. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
[TBL] [Abstract][Full Text] [Related]
20. Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report.
Ishibashi K; Nishina H; Ishiwata K; Ishii K
BMC Res Notes; 2015 Sep; 8():496. PubMed ID: 26419749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
